RxDoctor Payments Data

Sean Steenberge

Vascular Surgery · Cleveland, OHNPI 1700232469

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,718 of the $3,478 with a category attached, or 78.1%. 19 manufacturers reported payments, led by Silk Road Medical, Inc. at 29.8% of the total. Reporting peaked in 2024 at $1,513 and has fallen 60.2% since, to $602 in 2025. That places this record below the midpoint for vascular surgery clinicians in OH, where the typical reported total is $3,770.

$3,478in general payments, 2019–2025

Across 46 payments — averaging $75.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Silk Road Medical, Inc.$1K
  • Medtronic$958
  • Boston Scientific$363
  • W. L. Gore & Associates, Inc.$248
  • Inari Medical, Inc.$199
  • Endologix LLC$175
  • plus $500 from 13 others

What the payments were for

  • Travel & lodging$63618%
  • Food & beverage$2,71878%
  • Education$1244%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,478 in reported general payments places this provider in the 45th percentile of 213 vascular surgery providers in Ohio.

See all vascular surgery providers in Ohio →

Medicare billing

Part B allowed, 2024
$126,640
Medicare patients
1,012
Services billed
1,625

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban34$26,212
ClopidogrelClopidogrel Bisulfate41$444
Rosuvastatin Calcium37$408
Atorvastatin Calcium19$187

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Cleveland

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →